Approved antiviral drugs over the past 50 years
E De Clercq, G Li - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …
categorized into 13 functional groups have been formally approved for the treatment of the …
Antiviral drugs in influenza
M Świerczyńska, DM Mirowska-Guzel… - International journal of …, 2022 - mdpi.com
Flu is a serious health, medical, and economic problem, but no therapy is yet available that
has satisfactory results and reduces the occurrence of these problems. Nearly 20 years after …
has satisfactory results and reduces the occurrence of these problems. Nearly 20 years after …
[HTML][HTML] Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak …
TM Uyeki, HH Bernstein, JS Bradley… - Clinical Infectious …, 2019 - academic.oup.com
These clinical practice guidelines are an update of the guidelines published by the
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled …
MG Ison, S Portsmouth, Y Yoshida… - The Lancet Infectious …, 2020 - thelancet.com
Background Baloxavir marboxil (hereafter baloxavir), a selective inhibitor of influenza cap-
dependent endonuclease, was approved in 2018 in the USA and Japan for the treatment of …
dependent endonuclease, was approved in 2018 in the USA and Japan for the treatment of …
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
J Dobson, RJ Whitley, S Pocock, AS Monto - The Lancet, 2015 - thelancet.com
Background Despite widespread use, questions remain about the efficacy of oseltamivir in
the treatment of influenza. We aimed to do an individual patient data meta-analysis for all …
the treatment of influenza. We aimed to do an individual patient data meta-analysis for all …
Modulation of the immune response to respiratory viruses by vitamin D
CL Greiller, AR Martineau - Nutrients, 2015 - mdpi.com
Background: Vitamin D deficiency has been shown to be independently associated with
increased risk of viral acute respiratory infection (ARI) in a number of observational studies …
increased risk of viral acute respiratory infection (ARI) in a number of observational studies …
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of …
SG Muthuri, S Venkatesan, PR Myles… - The lancet Respiratory …, 2014 - thelancet.com
Background Neuraminidase inhibitors were widely used during the 2009–10 influenza A
H1N1 pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We …
H1N1 pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We …
Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis
D Mertz, TH Kim, J Johnstone, PP Lam, SP Kuster… - Bmj, 2013 - bmj.com
Objective To evaluate risk factors for severe outcomes in patients with seasonal and
pandemic influenza. Design Systematic review. Study selection Observational studies …
pandemic influenza. Design Systematic review. Study selection Observational studies …
Neuraminidase inhibitors for preventing and treating influenza in adults and children
T Jefferson, MA Jones, P Doshi… - Cochrane database …, 2014 - cochranelibrary.com
Background Neuraminidase inhibitors (NIs) are stockpiled and recommended by public
health agencies for treating and preventing seasonal and pandemic influenza. They are …
health agencies for treating and preventing seasonal and pandemic influenza. They are …
Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond
MD Parkins, BE Lee, N Acosta, M Bautista… - Clinical Microbiology …, 2024 - Am Soc Microbiol
Wastewater-based surveillance (WBS) has undergone dramatic advancement in the context
of the coronavirus disease 2019 (COVID-19) pandemic. The power and potential of this …
of the coronavirus disease 2019 (COVID-19) pandemic. The power and potential of this …